Copyright
©The Author(s) 2025.
World J Stem Cells. Feb 26, 2025; 17(2): 100621
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.100621
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.100621
Figure 1 Schematic illustration of the study design.
ASCT: Autologous stem cell transplantation; HDCT: High-dose chemotherapy; OS: Overall survival; EFS: Event-free survival; LDH: Lactate dehydrogenase.
Figure 2 Results of Kaplan-Meier analysis of patient overall survival and event-free survival.
A and B: Probabilities of overall survival (A) and event-free survival (B) for patients following the first autologous stem cell transplantation; C and D: Overall survival (C) and event-free survival (D) of patients in different groups after the first autologous stem cell transplantation. OS: Overall survival; EFS: Event-free survival.
Figure 3 Results of overall survival and event-free survival analysis for patients with neuroblastoma and other tumors.
A and B: Probabilities of overall survival (A) and event-free survival (B) in patients with neuroblastoma and other tumors; C and D: Overall survival (C) and event-free survival (D) of patients with neuroblastoma in different groups. OS: Overall survival; EFS: Event-free survival.
- Citation: Luo ZY, Fan LQ, Guo WL, Yang JP, Li ZY, Huang YX, Jiang H, Zhang XH. Effect of tandem autologous stem cell transplantation on survival in pediatric patients with high-risk solid tumors in South China. World J Stem Cells 2025; 17(2): 100621
- URL: https://www.wjgnet.com/1948-0210/full/v17/i2/100621.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i2.100621